First Patient Enrolled - YG1699 Type 1 Diabetes Phase llClinical Study in the United States

2022-07-08 00:00:00

Youngene Therapeutics Announced Today: The first patient has been enrolled in and the Type 1 Diabetes lla clinical trial has started. In the next a few days, successive patients will start to join the trial.The Type 1 Diabetes lla trial is expected to finish by the end of this year.